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Introduction: The heightened inﬂammatory phenotype associated with obesity has been linked to the development of
cardiovascular diseases. Short-term high-fat feeding induces a proinﬂammatory state that may impact the blood vessel
wall. CD11c, a signiﬁcantly increased dendritic cell biomarker during diet-induced obesity (DIO), may have a mechanistic
role in this high-fat feeding effect. We hypothesized that the proinﬂammatory effect of short-term DIO accelerates vein
bypass graft failure via CD11c-dependent mechanisms.
Methods: Male 9-week-old DIO mice (n [ 13, C57BL/6J recipients; n [ 6, CD11c-/- recipients) and normal chow
controls (n [ 15, C57BL/6J recipients; n [ 6, CD11c-/- recipients) underwent unilateral carotid interposition vein
isografting (inferior vena cava from the same diet and genetic background donor), with a midgraft or outﬂow focal
stenosis. Vein grafts were harvested at either 1 week (immunohistochemical staining for early CD11c expression) or
4 weeks later (morphometric analyses and CD11c evaluation).
Results: Despite a 40% larger body size, C57BL/6J DIO mice had 44% smaller poststenosis vein graft lumens (P [ .03)
than their controls via an acceleration of overall negative vein graft wall remodeling in the day-28 midgraft focal stenosis
model but not in the outﬂow stenosis model. Higher CD11c expression occurred in DIO midgraft-stenosis vein graft
walls, both at postoperative days 7 and 28. In contrast, with in vivo CD11c deﬁciency, DIO did not elicit this poststenotic
negative remodeling but attenuated intimal hyperplasia.
Conclusions: These ﬁndings highlight negative wall remodeling as a potential factor leading to vein graft failure and
provide direct evidence that short-term dietary alterations in the mammalian metabolic milieu can have lasting
implications related to acute vascular interventions. DIO induces negative mouse vein graft wall remodeling via
CD11c-depedent pathways. (J Vasc Surg 2014;59:1670-6.)
Clinical Relevance: Brief lifestyle and dietary modiﬁcations have been associated with dramatic changes in human
metabolic parameters. In the current study, short-term high-fat feeding of mice resulted in inward remodeling of vein
grafts (lumen loss via wall organization into a smaller conduit), and this appeared to occur by way of a protein (CD11c)
expressed on speciﬁc cell types such as dendritic cells. The ﬁndings support the relevance of the dietary-induced metabolic
state of mammals to their vascular response to injury. The work also emphasizes that factors beyond the blood vessel wall
likely contribute to vein graft adaptations and failure.Vein graft failure remains a too frequent outcome of
bypass grafting therapy for peripheral vascular or coronary
occlusive diseases.1-3 While biologic (including inﬂamma-
tion4-6) and biomechanical forces7,8 appear to contribute
to early vein graft wall adaptations, the events leading
to vein graft failure remain not well described.9-12 Further-
more, decades of research that focus on luminal vein graft
intimal hyperplasia have failed to produce effective preventa-
tive or therapeutic strategies.2,3,13 Emerging data support an
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Worldwide, there is an obesity epidemic, and a height-
ened inﬂammatory phenotype has clearly been associated
with obesity21 and speciﬁc clinical conditions such as uremia
and advanced vascular disease.22-24 Adipose tissue (particu-
larly perivascular white adipose25) is increasingly recognized
as a depot of proinﬂammatory mediators (leptin, TNF-a,
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Table. Day-28 experimental groups and numbers of
vein-grafted (recipient) mice
Midgraft focal
stenosis
Outﬂow focal
stenosis
C57BL/6J CD11c-/- C57BL/6J
Standard diet (normal) 5 6 7
High-fat diet (DIO) 5 6 5
DIO, Diet-induced obesity.
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the presence of obese states such as the metabolic syndrome
as a risk factor for accelerated vein graft failure.27
Vascular events such as endovascular injury can rapidly
and remarkably change perivascular adipose into a proin-
ﬂammatory phenotype.28 On the other hand, short-term
high-fat feeding induces a proinﬂammatory state in the
very “plastic” adipose tissue,18 and there is emerging
evidence that these adipocytes communicate with the blood
vessel wall.29-31 CD11c (primarily a classic dendritic cell
marker but also expressed in other cell types such as macro-
phages/monocytes) may have a mechanistic role in this
high-fat feeding effect.32 Due to its locality, high tissue
mass volume in the human body, and the vasoactive media-
tors that it synthesizes, we theorized that the phenotype of
adipose can impact the vascular response to acute hemody-
namic perturbation such as vein grafting. Speciﬁcally, herein
we directly tested the hypothesis that the inﬂammatory
phenotype resulting from short-term high-fat diet-induced
obesity (DIO) drives accelerated vein graft failure (increased
intimal hyperplasia, enhanced negative wall remodeling)
via CD11c-dependent mechanisms.
METHODS
Animals and experimental groups. All animal exper-
iments were performed according to the protocols
approved by the Institutional Animal Care and Use
Committee of Brigham and Women’s Hospital, Harvard
Medical School, and complied with the Guide for the
Care and Use of Laboratory Animals (National Institutes
of Health Publication No. 85-23, Revised 1996).
DIO mice (#380050) and their C57BL/6J (C57)
controls (#380056) were purchased from the Jackson Labo-
ratory (BarHarbor,Me). CD11c knockoutmice (CD11c-/-;
C57BL/6 background; breeders were a generous gift of
Christie M. Ballantyne, MD, Baylor College of Medicine,
Houston, Tex) were bred in our colony at Brigham and
Women’s Hospital. At 6 weeks of age, all these male mice
were fed with a 60-kcal% high-fat (DIO; #D12492) or
a 10-kcal% normal chow diet (#D12450B) from Research
Diets Inc (New Brunswick, NJ). At 9 weeks of age, all the
recipient mice underwent vein bypass isografting with
a midgraft or outﬂow focal stenosis,33 and the donor mice
were of the same genetic background, age, gender, and
diet type with their recipients. Recipient mice were main-
tained on a 12-hour light-dark cycle, received water ad libi-
tum, and remained on their assigned diet until sacriﬁce at
postoperative day 28. Body weight and urine dipstick test
(LWScientiﬁc Inc, Lawrenceville, Ga) weremonitored every
week. Experimental groupings are shown in the Table.
In a separate experiment, C57-DIO and C57-normal
chow mice (n ¼ 3 recipient mice, respectively) underwent
vein isografting with midgraft focal ﬂow restriction. These
mice were sacriﬁced at postoperative day 7 for CD11c
immunohistochemical staining on vein graft cryosections,
which are better than parafﬁn sections to detect the antigen.
Murine vein graft models. Mice from each dietary
group underwent a unilateral carotid interposition veinisografting, using an anastomotic cuff technique34,35 and
two distinct ﬂow restriction manipulations.33 Brieﬂy, under
general continuous isoﬂurane inhalant anesthesia (2%
during painful stimuli, and 1% at latent periods) and using
a Zeiss OPMI-MD surgical microscope (Carl Zeiss Inc,
Oberkocken, Germany), the common carotid artery of the
recipient animal was divided, and the cut ends were everted
over hand-fashioned polyetheretherketone cuffs (Zeus Inc,
Orangeburg, SC), which had a 0.51-mm outside diameter
and a 0.41-mm inside diameter. The supradiaphragmatic
inferior vena cava from the donor mouse was quickly har-
vested, ﬂushed with heparinized saline (100 IU/mL),
placed over the everted arterial ends, and secured with a 9-
0 nylon suture.
Flow restrictions were achieved via creation of a focal
stenosis at one of two different locations. This was achieved
by either tying a 9-0 nylon ligature around the middle
portion of the vein graft and a 32-gauge blunt mandrel
needle (outside diameter, 0.23 mm; Hamilton Co, Reno,
Nev), or around the outﬂow common carotid artery (at
the location of 1 mm beyond the distal cuff body) and
a 33-gauge blunt needle (outside diameter 0.21 mm,
Hamilton Co), and then the needle was gently removed
to restore blood ﬂow. The vessel lumen size of stenosis
site immediately after surgery was roughly equal to the
outside diameter of the utilized needle. Only one ﬂow-
restriction manipulation per mouse was completed. The
midgraft focal stenosis induces primary wall remodeling
with modest intimal hyperplasia, and the outﬂow focal
stenosis model generates relatively more intimal hyperplasia
than wall remodeling.33
A Canon EOS Rebel T1i SLR camera (Canon Inc,
Lake Success, NY) connecting to the surgical microscope
was utilized to microphotograph the vein graft immediately
after grafting for analyzing external dimensions as we previ-
ously reported.33 Vein graft patency was monitored by
intraoperative ﬂowmetry (Transonic TS420; Transonic
Systems Inc, Ithaca, NY) and postoperative (days 4 and
27) duplex ultrasonography (Vevo 2100 Imaging System;
VisualSonics, Toronto, Ontario, Canada).
Tissue harvest and processing. The vein grafts were
harvested at day 7 postoperatively to evaluate the early vein
graft CD11c expression, or at day 28 to evaluate vein graft
wall morphology and later time-point CD11c expression.
Under general anesthesia, the recipient mice were
whole-body blood ﬂushed with saline via intravascular
Fig 1. Weight curves of vein-grafted mice (C57BL/6J or
CD11c-/-) with 60-kcal% high-fat diet (diet-induced obesity
[DIO]) or 10-kcal% standard chow (Normal). Values are shown as
mean 6 standard error of the mean.
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harvested immediately and embedded into Optimal
Cutting Temperature compound for cryosectioning. Day-
28 mice were perfusion ﬁxed under physiologic pressure
(100 mm Hg) with 10% formalin, then the vein grafts
were harvested, tissue processed, and embedded into
parafﬁn for sectioning.
Morphometry. Rather than the day-7 vein grafts,
which still have less morphological changes based on our
previous experience, we utilized the day-28 formalin-ﬁxed
vein grafts to do morphometric analysis. Serial cross-
sections 200 mm, 400 mm, 600 mm, and 800 mm proximal
and distal to the midgraft stenosis were selected in the
midgraft focal stenosis models, and the graft sections
400 mm and 600 mm from the proximal cuff edge were
selected in the outﬂow focal stenosis models. All sections
were stained with Masson’s trichrome staining, and a Zeiss
Axio A1 microscope (Carl Zeiss Inc) was used to capture
digital microscopic images. Lumen circumference, internal
elastic lamina (IEL), and outside boundary of the vein graft
were delineated, and the morphometric analysis was
completed as we previously described.33,35,36
Immunohistochemistry. CD11c immunohistochem-
ical staining was completed on 6-mm-thick day-7 frozen
sections or day-28 formalin-ﬁxed parafﬁn sections from
midgraft stenosis mouse (C57 normal chow vs C57 DIO)
vein grafts. All sections were selected from themiddle portion
of the distal half of vein grafts to avoid foreign body reaction
to the suture and the cuff. Frozen sections were ﬁxed by ice-
cold acetone for 10 minutes. Parafﬁn sections were antigen
retrieved using a citrate buffermethod before antibodies were
applied. Hamster anti-Mouse CD11c (1:100; #550283; BD
Pharmingen, San Jose, Calif) primary antibody and Goat
anti-Armenian Hamster IgG (1:400; #ab5744; Abcam,
Cambridge, Mass) secondary antibody were selected.
Statistical analyses. All data are expressed as means 6
standard error of the mean. Comparisons were completed
with the use of one-way analysis of variance or unpaired two-
tailed Student t-test, via SigmaPlot v11.0 (Systat Software
Inc, San Jose, Calif) and Excel 2003 (Microsoft Corp, Red-
mond, Wash). P < .05 was considered statistically signiﬁcant.
RESULTS
High-fat diet induces obesity. Compared with its
normal chow counterpart (same genetic background),
high-fat diet C57 mice had signiﬁcantly higher weight at
each time point (P < .01, respectively; Fig 1): 27% heavier
at the time of vein graft placement (age, 9 weeks) and 38%
by the time of harvest (age, 13 weeks). The CD11c-/- mice
were 38% heavier at week 9 and 42% heavier at week 13.
CD11c-/- mice did not reach statistical difference in the
weight gain with their counterpart C57 mice on the same
diet, although there may be a trend toward more weight
gain in the knockout setting. None of the mice had glu-
cosuria, and no animal suffered clinically apparent sequela
related to their surgical vein grafts. We did not record the
blood lipid and glucose proﬁles because these parameters
have been previously reported.37,38DIO induces negative wall remodeling in the
midgraft focal stenosis model. The implanted inferior
vena cava from C57 normal chow vs C57 DIO mice
have no signiﬁcant difference in external vessel dimensions
based on our high-resolution micrography immediately
after surgery. In our validated mouse midgraft focal
stenosis (w80% lumen narrowing) model,33 3 weeks of
preoperative and 4 weeks of postoperative high-fat DIO
diet signiﬁcantly induced negative remodeling (overall 44%
lumen size decrease in the poststenosis 200-600 mm
portion; P ¼ .03; Fig 2, A) despite the larger body size in
the DIO animals. This lumen loss was not due to accel-
erated intimal hyperplasia, or other differentials in wall
thickness (all layer thicknesses and intima/[media þ
adventitia] ratio were equivalent; Fig 2, C-E), but rather an
acceleration of overall negative wall remodeling (vein
graft IEL perimeter 24% shorter at the poststenosis
200-600 mm portion; P ¼ .03; Fig 2, B). Interestingly,
in the relatively high intimal hyperplasia generating outﬂow
focal stenosis model, this pattern was not observed
(Fig 3, A and B).
CD11c is highly expressed in C57-DIO vein graft
wall. CD11c expression was more prevalent via immuno-
histochemistry in C57-DIO midgraft stenosis vein graft
wall, compared with their C57-normal chow controls,
both on days 7 and 28 postoperatively (P < .05, respec-
tively). This expression localized primarily to the adven-
titia or soft tissue immediately adjacent to the vein grafts
(Fig 4).
CD11c deﬁciency offset the effect of DIO on vein
graft wall negative remodeling. Under CD11c-/- condi-
tions, DIO did not elicit negative vein graft wall remodel-
ing in the midgraft focal stenosis model (Fig 2, F and G). A
trend toward less intimal hyperplasia was observed in the
poststenosis 200 mm to 400 mm portion (56% decrease in
intimal thickness; P ¼ .07; 65% decrease in intima/
[mediaþ adventitia] thickness ratio; P¼ .04; Fig 2,H and J).
Furthermore, with DIO and midgraft stenotic grafting,
lack of CD11c increased the prestenosis lumen size by 32%
(P ¼ .03) and decreased poststenosis intimal thickness by
Fig 2. Serial cross-sectional analysis of vein graft (midgraft portion) wall adaptation in C57BL/6J (A-E) and CD11c-/-
(F-J), normal chow vs diet-induced obesity (DIO) mouse midgraft focal stenosis model. A and F,Mean calculated lumen
area. B and G, Mean internal elastic lamina (IEL) perimeter. C and H,Mean intima thickness. D and I,Mean media þ
adventitia thickness. E and J,Mean intima/(media þ adventitia) thickness ratio. Values were shown as means6 standard
error of the mean. *P < .05 and **P < .01 vs the same location of vein graft in normal chow counterpart mice. K-N,
Representative Masson’s trichrome stained images at 400 mm distal to midgraft focal stenosis (D400).K,C57 Normal. L,
C57DIO.M,CD11c-/- Normal.N,CD11c-/- DIO. Three hand-drawn black lines in each image delineate the boundaries
of different layers of vein graft wall. From the lumen to the outside: lumenboundary, IEL, and outsideboundary. Scale bar¼
200 mm.
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Fig 3. Morphologic analysis of vein graft wall adaptation with outﬂow focal stenosis, in C57BL/6J normal chow vs
diet-induced obesity (DIO) mice. A, Mean calculated lumen area. B, Mean internal elastic lamina (IEL) perimeter. C,
Mean intima thickness. D, Mean media þ adventitia thickness. E, Mean intima/(media þ adventitia) thickness ratio.
Values were shown as means 6 standard error of the mean.
Fig 4. The representative CD11c immunohistochemical images and the quantitative analysis of midgraft stenotic vein
graft wall in C57BL/6J normal chow vs diet-induced obesity (DIO) mice. Day-7 vein grafts were acetone ﬁxed and
cryosectioned; day-28 grafts were formalin ﬁxed and citrate buffer prepared. Note the brown membrane labeling of
irregular-shaped cells mainly in the adventitial or adjacent soft tissue of vein graft wall. Scale bars ¼ 50 mm. *P < .05 vs
C57 normal chow mice at the same time point. SEM, Standard error of the mean.
JOURNAL OF VASCULAR SURGERY
1674 Yu et al June 201442% (P ¼ .01). But interestingly, in normal chow-fed mice,
CD11c-/- reduced the overall vein graft lumen size,
without a change in intimal hyperplasia.
DISCUSSION
Occlusive vascular pathologies have historically been
associated with genetic and long-term endogenous
(diabetes, hyperlipidemic states, hypertension, etc) and envi-
ronmental (smoking) factors. However, emerging data
suggest that short-term manipulations can lead to perturba-
tions in signaling pathways associated with vascular patholo-
gies.20 While linkage of these manipulations to long-term,
clinically relevant phenotypes proves difﬁcult, the vascular
response to interventions such as vein graftingoffers a unique
window into the interplay of physical and biologic factors in
host adaptations.39Inﬂammation has long been associated with accelerated
vein graft failure.4,5,6,10,40 Adipose tissue (particularly peri-
vascular white adipose25) is increasingly recognized as
a depot of a variety of bioactivemediators.26 Recent research
found that short-term high-fat feeding induced an altered
systemic inﬂammatory state,18 as evidenced by the increased
number of circulating CD11c-positive cells.32 These dietary
perturbations also impact baseline adipose phenotype as well
as the adipose response to surgical trauma.41 Our immuno-
histochemical staining also showed a signiﬁcant increase of
CD11c expression in DIO day-7 and day-28 vein graft walls
(mainly at adventitia lamina), which implicated a possible
role of CD11c-positive cells, possibly via an “outside-in”
route, in vein graft wall adaptation.
Our morphological results demonstrate that, despite
holding a substantially larger body size, the C57-DIO
JOURNAL OF VASCULAR SURGERY
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portion of a midgraft stenotic vein graft after just 4 weeks
(Fig 2, A). This lumen loss was not due to accelerated
intimal hyperplasia but rather an acceleration of overall
negative wall remodeling (Fig 2, B). Interestingly, in the
setting of absent CD11c, DIO mice did not show the
same difference (Fig 2, F and G), supporting potential
involvement of CD11c in these processes. Compared with
themidgraft stenosismodel, whichmimics an advanced focal
vein graft narrowing and induces a signiﬁcant post-stenotic
wall remodeling, the outﬂow stenosis model can induce
a broad but moderate lumen narrowing with limited wall
remodeling. These two models’ distinct characteristics may
underlie the differential ﬁndings between the two settings.
Several other research groups have probed the effect of
systemic metabolic conditions on the vascular response to
injury.28,42 We did not observe signiﬁcantly changed intimal
hyperplasia in wild-type DIO mice, both in a midgraft
stenosis model (Fig 2, C-E) and an outﬂow stenosis model
(Fig 3, C-E), although the latter model is more powerful
to induce an overall intimal thickening response.33 Again,
without CD11c signaling, DIO mice tended to have
decreased intimal thickening (Fig 2, H and J). Thus, while
these loss-of-function experiments support a probable role
for CD11c in these vascular adaptations under complex
conditions, an acknowledged limitation is an inability to
completely delineate the detailed molecular mechanismsd
for instance, CD11c-dependent and -independent mecha-
nisms of adaptations such as intimal hyperplasia.
While completed as carefully as technically possible,
another limitation of our approach remains the utilization
of histologic morphology as a surrogate for in vivo vein graft
anatomy. We are exploring imaging techniques such as du-
plex and magnetic resonance angiography to deﬁne longitu-
dinal in vivo vein graft anatomy, but the small scale remains
challenging. Utilization of such imaging approaches would
augment the ability to explore mechanistic links since tissues
would be available for molecular analyses for individual
animals. Employing this high-fat DIO mouse model, it is not
completely possible to unravel whether the effects observed are
due to the obese phenotype or the high-fat feeding, but this
circumstance certainly holds relevance for the clinical condition.
Finally, the results of this study seemingly contradict
those of Wong et al, who found accelerated expansive
vein graft remodeling in rabbits fed with a high-cholesterol
diet.16 Differences may be explained by differences in the
time periods examined, species, and measurement method-
ologies. The heterogeneity of results in these murine and
rabbit models suggests a complex environment that is prob-
ably dependent on the speciﬁcs of the vascular injury and
point to this area as being fertile for further investigation.
CONCLUSIONS
We found that short-term high-fat-diet feeding can
signiﬁcantly induce mouse vein graft wall negative remod-
eling, and in this setting, it appears to occur via CD11c-
dependent pathways. This work supports involvement of
short-term dietary factors acting via speciﬁc signalingnetworks toward the midterm adaptations of the vascular
response to injury.
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